azilsartan vs olmesartan
Side-by-side comparison of azilsartan and olmesartan Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Edarbi
Benicar
Edarbyclor is a drug that combines two medicines to lower high blood pressure. It helps reduce the risk of strokes and heart attacks.
Olmesartan and hydrochlorothiazide is a drug that lowers high blood pressure. It contains two medicines that work together to help relax your blood vessels and remove extra salt and water from your body.
Edarbyclor is used to treat high blood pressure. It can be used if one medicine isn't enough to control your blood pressure. It can also be used as the first medicine if you likely need more than one drug. Lowering blood pressure helps prevent strokes and heart attacks.
This medicine is used to treat high blood pressure (hypertension). Lowering blood pressure reduces the risk of strokes and heart attacks. It may be used alone or with other blood pressure medicines.
Edarbyclor contains two medicines that work in different ways to lower blood pressure. One medicine blocks a substance that tightens blood vessels. The other medicine helps your body get rid of extra salt and water.
Olmesartan blocks a substance in your body that tightens blood vessels, so blood flows more smoothly. Hydrochlorothiazide is a diuretic, which helps your body get rid of extra salt and water. This lowers blood pressure.
- • Dizziness
- • Fatigue
- • Nausea
- • High uric acid levels in the blood
- • Dizziness
- • Upper respiratory infection (like a cold)
No adverse event reports.
No adverse event reports.
Edarbyclor can harm your unborn baby. If you are pregnant or become pregnant, stop taking this medicine and tell your doctor right away.
This medicine can harm your unborn baby. If you are pregnant or plan to become pregnant, tell your doctor right away. Stop taking this medicine as soon as you know you are pregnant.
Edarbyclor can cause harm to an unborn baby, including injury or death. Do not take this medicine if you are pregnant or plan to become pregnant. It is not recommended to breastfeed while taking Edarbyclor.
Do not use this medicine if you are pregnant. It can cause serious harm or death to your unborn baby, especially during the second and third trimesters. Talk to your doctor about other blood pressure medicines if you are breastfeeding or plan to breastfeed, as this medication may pass into breast milk.
Also Compare — Nearby Drugs
Compare azilsartan with
Compare olmesartan with
How to Read This azilsartan vs olmesartan Comparison
azilsartan is classified in the Angiotensin II Receptor Blocker (ARB) drug class, while olmesartan sits within the Angiotensin II Receptor Blocker (ARB) class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, azilsartan has 0 submissions while olmesartan has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between azilsartan and olmesartan — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.